Satellite Sessions (NON-CME Industry Sessions)

LumiThera

14/06/2019 | 11.45 - 12.45hrs | Gallieni Room 1 + 2

View programme Register interest

Programme Details

Session Title: Photobiomodulation: An Innovative, Mitochondria-targeted Therapy for Dry AMD and Other Ocular Diseases

Title: Photobiomodulation For The Treatment Of Retinal And Optic Nerve Disease
Speaker: Janis Eells, Ph.D.
Affiliations: Department of Biomedical Sciences, UW-Milwaukee; Departments of Ophthalmology and Cell Biology, Molecular Biology and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA

Title: LIGHTSITE I Clinical Analysis Of The Safety And Efficacy Of Photobiomodulation In Subjects With Dry Age-Related Macular Degeneration
Speaker: Samuel N. Markowitz, M.D., FRCS(C)
Affiliations: Department of Ophthalmology, University of Toronto, Ontario, Canada

Title: LIGHTSITE I Morphological Analysis: Evaluating The Impact Of Photobiomodulation Using Multimodal Imaging
Speaker: Marion Munk, M.D., Ph.D.
Affiliations: Department of Ophthalmology, Inselsipital University Hospital, Berne, Switzerland; Department of Ophthalmology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA

Santen

14/06/2019 | 11.45 - 12.45hrs | Uranie Room

View programme Register interest

Programme Details

Session Title: Long-term solutions in dry eye disease

11.45 - 11.50 Welcome and introductions - Prof. Steffen Heegaard, Denmark

11.50 - 12.00 Cases in focus: the burden of dry eye disease - Prof. Elisabeth Messmer, Germany

12.00 - 12.15 Relieving symptoms: where to start? - Prof. Maite Sainz de la Maza, Spain

12.15 - 12.30 The long-term view:
what the evidence tells us about treatment with ciclosporin A 0.1% CE (cationic emulsion)
- Prof. Andrea Leonardi, Italy

12.30 - 12.40 Cases in focus: effective management of dry eye disease - Prof. Elisabeth Messmer, Germany

12.40 - 12.45 Q and A, summary and close - Prof. Steffen Heegaard, Denmark

Novartis

15/06/2019 | 07.00 - 08.00hrs | Gallieni Room 1 + 2

View programme Register interest

Programme Details

Session Title: Innovations in retinal diseases for patients of all ages

President : Pr Catherine Creuzot-Garcher
07:00 - 07:05 - President’s opening words

07:05 - 07:20 - Retinopathy of prematurity : the role and benefit of anti-VEGF - Pr Frédéric Matonti

07:20 - 07:40 - Retinitis pigmentosa : early successes of gene therapy - Pr Isabelle Audo

07:40 - 08:00 - Age-related macular degeneration : recent advances in treatments - Pr Catherine Creuzot-Garcher

Santen

15/06/2019 | 11.45 - 12.45hrs | Uranie Room

View programme Register interest

Programme Details

Session Title: Glaucoma treatment: a question of balance

11:45 – 11:50 Welcome and introduction - Professor Carlo E. Traverso (Chair, Italy)

11:50 – 12:05 Why is 24-hour IOP control important in glaucoma management? - Dr Francesco Oddone (Italy)

12:05 – 12:20 Optimizing stepwise 24-hour IOP control: what does the evidence tell us? - Professor Anastasios G.P. Konstas (Greece)

12:20 – 12:35 What patients need: an optimal balance between efficacy and tolerability - Professor Carlo E. Traverso (Italy)

12:35 – 12:45 Q&A and closing remarks All/Chair

  • This field is for validation purposes and should be left unchanged.